These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10494289)
21. Recent developments in the management of bladder cancer: Introduction. Smith AB Urol Oncol; 2018 Mar; 36(3):95-96. PubMed ID: 29158137 [TBL] [Abstract][Full Text] [Related]
22. Histological changes due to intravesical instillation of mitomycin C. Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786 [TBL] [Abstract][Full Text] [Related]
23. Future therapies for the treatment of bladder neoplasms. See WA; Berman CJ Semin Surg Oncol; 1997; 13(5):376-88. PubMed ID: 9259094 [TBL] [Abstract][Full Text] [Related]
24. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. Bansal A; Kumar N; Sharma SC J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698 [TBL] [Abstract][Full Text] [Related]
25. Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. Tree AC; Jones K; Hafeez S; Sharabiani MTA; Harrington KJ; Lalondrelle S; Ahmed M; Huddart RA Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1168-1171. PubMed ID: 30012528 [TBL] [Abstract][Full Text] [Related]
26. Correspondence re: W. Paile's letter to the editor. Cancer Res., 60: 1146, 2000. Romanenko A; Vozianov A; Morimura K; Fukushima S Cancer Res; 2001 Sep; 61(18):6964-5. PubMed ID: 11559577 [No Abstract] [Full Text] [Related]
27. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684 [TBL] [Abstract][Full Text] [Related]
28. Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23. Herr HW Eur Urol; 2008 Jul; 54(1):23-4. PubMed ID: 18262335 [No Abstract] [Full Text] [Related]
29. Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma. Corradi RB; LaRosa S; Jebiwott S; Murray KS; Rosenzweig B; Somma AJ; Gomez RS; Scherz A; Kim K; Coleman JA Int J Urol; 2019 Mar; 26(3):414-422. PubMed ID: 30659668 [TBL] [Abstract][Full Text] [Related]
31. Radiation Induced Cystitis and Proctitis - Prediction, Assessment and Management. Mallick S; Madan R; Julka PK; Rath GK Asian Pac J Cancer Prev; 2015; 16(14):5589-94. PubMed ID: 26320421 [TBL] [Abstract][Full Text] [Related]
32. Recent developments in the treatment of advanced bladder cancer. Godwin JL; Hoffman-Censits J; Plimack E Urol Oncol; 2018 Mar; 36(3):109-114. PubMed ID: 29395952 [TBL] [Abstract][Full Text] [Related]
33. [Carcinoma in situ of the urinary bladder--definition and status of treatment]. Otto T; Rübben H Urologe A; 1991 May; 30(3):163-6. PubMed ID: 1871934 [TBL] [Abstract][Full Text] [Related]
39. New horizons for GAG therapy in the management of urothelial damage. Lazzeri M Urologia; 2015 Oct; 82 Suppl 3():S10-4. PubMed ID: 26496969 [TBL] [Abstract][Full Text] [Related]